Zhenyu Zhong

Sep 19, 2024 | onlinelibrary.wiley.com | Ziyuan Chen |Zhenyu Zhong |Tianqi Li |Mingkao YUAN

Supporting Information Supplementary data to this article can be found online at http://doi.org/10.1111/1755-6724.15206. Filename Description acgs15206-sup-0001-S1.docx111.8 KB Supporting Information References , , , and , 1991. An improved set of a-X parameters for Fe-Mg-Ca garnets and refinements of the orthopyroxene-garnet thermometer and the orthopyroxene-garnet-plagioclase-quartz barometer. Journal of Petrology, 32(3): 629–656. , 1987.

Jun 24, 2023 | nature.com | Zhenyu Zhong

AbstractBiologics are increasingly used to treat Vogt-Koyanagi-Harada disease, but head-to-head comparisons with conventional immunosuppressants are lacking. Here in this randomized trial (Chinese Clinical Trial Registry, ChiCTR2100043061), we assigned 110 patients (27 early-phase and 83 late-phase) to cyclosporine-based immunosuppressant strategy (N = 56) or adalimumab-based biologic strategy (N = 54), each combined with a modified corticosteroid regimen.